Physician profile
Kelley J Farner
NPI 1346337623
$5,666.73
in general payments reported to CMS, 2019-2025
11 companies · $3,810 in 2025
The $3,810 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.90 · 2022: $795 · 2023: $385 · 2024: $611 · 2025: $3,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,438 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,238 · Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,437.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,237.50 |
| Food and Beverage | $1,130.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $3,675.24 | 2025 | Epicel (Cultured Epidermal Autografts) |
| Access Pro Medical, LLC | $931.31 | 2022-2023 | Matriderm |
| Smith+Nephew, INC. | $557.51 | 2021-2025 | Collagenase Santyl, Oasis, Versajet |
| Avita Medical Americas, LLC | $164.40 | 2024 | |
| Acumed LLC | $118.60 | 2024 | Acumed, Inframe Implant, Innate Implant |
| Abbvie INC. | $95.92 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $40.92 | 2023-2025 | Exparel, Iovera |
| Medline Industries LP | $32.77 | 2025 | |
| Solventum Corporation | $18.19 | 2025 | Promogran Prisma, Activ.A.C., 3m Cavilon |
| Misonix INC | $16.36 | 2021 | |
| Kci USA, INC. | $15.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Farner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.